VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ASBPWAspire Biopharma Holdings, Inc.
$0.03$45596
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksASBPWQuarterly Balance Sheet

Aspire Biopharma Holdings, Inc. (ASBPW) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Aspire Biopharma Holdings, Inc. (ASBPW) quarterly balance sheet — complete assets, liabilities & equity history

ASBPW Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Total Current Assets7.12M1.31M2.4M989.42K1.97M147.99K61.81K342.97K65.58K81.22K253.36K546.14K
Cash & Short-Term Investments5.86M1M1.95M206.23K1.35M3.63K6.6M19.6K00280125.2K
Cash Only5.86M1M1.95M206.23K1.35M3.63K6.6M000280125.2K
Short-Term Investments000000000000
Accounts Receivable0000036.5K25.03K299.92K0000
Days Sales Outstanding------------
Inventory369.97K253.16K35.44K000000000
Days Inventory Outstanding1.24K2.52K3.08K---------
Other Current Assets890.15K0000-36.5K-6.73M23.45K65.58K81.22K253.08K420.94K
Total Non-Current Assets000006.67M6.6M6.52M20.14M19.9M19.64M20.02M
Property, Plant & Equipment000000000000
Fixed Asset Turnover------------
Goodwill000000000000
Intangible Assets00000005.01M0000
Long-Term Investments000006.67M6.6M6.52M20.14M19.9M19.64M20.02M
Other Non-Current Assets000000-5.03M-5.01M0000
Total Assets7.12M1.31M2.4M989.42K1.97M147.99K6.66M6.87M20.2M19.98M19.89M20.56M
Asset Turnover0.01x0.00x0.00x---------
Asset Growth %262.1%786.66%-63.93%-85.59%-90.27%-99.26%-66.51%-66.6%-93.34%-93.34%-93.32%-93.07%
Total Current Liabilities3.15M7.59M13.86M10.56M8.87M1.69M6.57M6.24M2.63M403.33K316.32K284.36K
Accounts Payable857.92K1.01M1.06M1.35M1.43M310.22K903.69K584.08K365.01K152K104.38K101.67K
Days Payables Outstanding3.73K18.15K104.99K---------
Short-Term Debt499.21K1.38M1.38M1.83M1.71M1.27M436.28K5.36M2M12.38K00
Deferred Revenue (Current)000000000000
Other Current Liabilities1.8M4.84M11.41M6.64M5.05M111.03K4.9M00000
Current Ratio2.26x0.17x0.17x0.09x0.22x0.09x0.01x0.05x0.02x0.20x0.80x1.92x
Quick Ratio2.14x0.14x0.17x0.09x0.22x0.09x0.01x0.05x0.02x0.20x0.80x1.92x
Cash Conversion Cycle------------
Total Non-Current Liabilities96.25K95.66K9.9K49.28K49.3K003.85M0000
Long-Term Debt000000000000
Capital Lease Obligations000000000000
Deferred Tax Liabilities000000000000
Other Non-Current Liabilities96.25K95.66K9.9K49.28K49.3K003.85M0000
Total Liabilities3.25M7.69M13.87M10.61M8.92M1.69M6.57M6.24M2.63M403.33K316.32K284.36K
Total Debt499.21K1.38M1.38M1.83M1.71M1.27M436.28K5.36M2M12.38K00
Net Debt-5.36M380.87K-563.49K1.62M364.02K1.26M-6.17M5.36M2M12.38K-280-125.2K
Debt / Equity0.13x-----4.83x8.54x0.11x0.00x--
Debt / EBITDA--1.58x---------
Net Debt / EBITDA---0.64x---------508.95x
Interest Coverage-1.03x-0.30x-0.25x-2.75x-53.98x-17.57x--1.89x-12.46x-15.84x--
Total Equity3.87M-6.38M-11.47M-9.62M-6.95M-1.54M90.28K627.3K17.57M19.58M19.58M20.28M
Equity Growth %155.64%-314.02%-12801.2%-1633.03%-139.58%-107.87%-99.54%-96.91%-93.98%-93.23%-93.17%-92.9%
Book Value per Share2.59-4.27-9.26-7.80-7.34-2.230.130.9125.4630.7530.7525.55
Total Shareholders' Equity3.87M-6.38M-11.47M-9.62M-6.95M-1.54M90.28K627.3K17.57M19.58M19.58M20.28M
Common Stock173534.95K4.95K4.89K169.99K6.6M6.53M20.14M19.9M19.64M20.02M
Retained Earnings-30.48M-27.26M-22.55M-20.7M-18.72M-2.78M-15.38M-14.76M-13.99M-11.29M-10.88M-10.55M
Treasury Stock000000000000
Accumulated OCI000000000000
Minority Interest000000000000